University Health Network, Princess Margaret Cancer Centre

Toronto M5G 2M9

4 studies enrolling now · 9 studies all time

What they study most

Advanced Ovarian Carcinoma, Advanced Solid Tumor, Colorectal Cancer, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Serous Neoplasm, Fallopian Tube Transitional Cell Carcinoma, Gastric Cancer, Gastro-Oesophageal Cancer, Gastroesophageal Junction Cancer, Hodgkin Lymphoma, Ovarian Clear Cell Adenocarcinoma

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• Brentuximab Vedotin in Early Stage Hodgkin Lymphoma — Recruiting now
• Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial — Recruiting now
• Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors — Recruiting now
• Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) — Running, not enrolling
• Study of GS-4528 in Adults With Solid Tumors — Running, not enrolling
• Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors — Running, not enrolling
• A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer — Status unconfirmed